FOSCAVIR Drug Patent Profile

✉ Email this page to a colleague

Which patents cover Foscavir, and when can generic versions of Foscavir launch?

Foscavir is a drug marketed by Clinigen Hlthcare and is included in one NDA.

The generic ingredient in FOSCAVIR is foscarnet sodium. There are seven drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the foscarnet sodium profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Foscavir

A generic version of FOSCAVIR was approved as foscarnet sodium by FRESENIUS KABI USA on January 29^th, 2021.

Sign Up

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for FOSCAVIR?
What are the global sales for FOSCAVIR?
What is Average Wholesale Price for FOSCAVIR?

Summary for FOSCAVIR

US Patents:	0
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	1
Raw Ingredient (Bulk) Api Vendors:	89
Clinical Trials:	9
Patent Applications:	3,218
Drug Prices:	Drug price information for FOSCAVIR
What excipients (inactive ingredients) are in FOSCAVIR?	FOSCAVIR excipients list
DailyMed Link:	FOSCAVIR at DailyMed

Drug patent expirations by year for FOSCAVIR

Recent Clinical Trials for FOSCAVIR

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Biotest	Phase 2
University Hospital, Lille	Phase 2
City of Hope Medical Center

See all FOSCAVIR clinical trials

Pharmacology for FOSCAVIR

Drug Class	Pyrophosphate Analog DNA Polymerase Inhibitor
Mechanism of Action	Chelating Activity DNA Polymerase Inhibitors

US Patents and Regulatory Information for FOSCAVIR

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Clinigen Hlthcare	FOSCAVIR	foscarnet sodium	INJECTABLE;INJECTION	020068-001	Sep 27, 1991	AP	RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for FOSCAVIR

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Clinigen Hlthcare	FOSCAVIR	foscarnet sodium	INJECTABLE;INJECTION	020068-001	Sep 27, 1991	⤷ Sign Up	⤷ Sign Up
Clinigen Hlthcare	FOSCAVIR	foscarnet sodium	INJECTABLE;INJECTION	020068-001	Sep 27, 1991	⤷ Sign Up	⤷ Sign Up
Clinigen Hlthcare	FOSCAVIR	foscarnet sodium	INJECTABLE;INJECTION	020068-001	Sep 27, 1991	⤷ Sign Up	⤷ Sign Up
Clinigen Hlthcare	FOSCAVIR	foscarnet sodium	INJECTABLE;INJECTION	020068-001	Sep 27, 1991	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for FOSCAVIR

See the table below for patents covering FOSCAVIR around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
Denmark	288877		⤷ Sign Up
Netherlands	930053		⤷ Sign Up
Netherlands	7707235		⤷ Sign Up
Ireland	45753	COMPOSITION AND METHOD FOR COMBATING VIRUS INFECTIONS	⤷ Sign Up
Australia	510809		⤷ Sign Up
Hong Kong	28984	COMPOSITION AND METHOD FOR COMBATING VIRUS INFECTIONS	⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

AI Research Assistant

Questions you can ask:

Summary for FOSCAVIR

Recent Clinical Trials for FOSCAVIR

Pharmacology for FOSCAVIR

Make Better Decisions: Try a trial or see plans & pricing